Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Evoke Pharma, Inc. (EVOK) had Revenue of $10.25M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$10.25M
Net Income	$-5.35M
Cost of Goods Sold	$0.36M
Gross Profit	$9.89M
Operating Expenses	$15.45M
Operating Income	$-5.20M
Non-Operating Income/Expense	$-0.15M
Pre-Tax Income	$-5.35M
Normalized Pre-Tax Income	$-5.35M
Income after Taxes	$-5.35M
Income from Continuous Operations	$-5.35M
Consolidated Net Income/Loss	$-5.35M
Normalized Income after Taxes	$-5.35M
EBIT	$-5.20M
EBITDA	$-5.20M
Weighted-Average Shares Outstanding (Basic)	1.91M
Weighted-Average Shares Outstanding (Diluted)	1.91M
Earnings per Share (EPS) (Basic)	$-2.81
Earnings per Share (EPS) (Diluted)	$-2.81
Balance Sheet Financials
Current Assets	$17.24M
Property, Plant, and Equipment	--
Long-Term Assets	$0.28M
Total Assets	$17.52M
Current Liabilities	$10.38M
Long-Term Debt	--
Long-Term Liabilities	$0.10M
Total Liabilities	$10.48M
Common Equity	$7.04M
Tangible Shareholders Equity	$7.04M
Shareholders Equity	$7.04M
Common Shares Outstanding	1.49M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-5.46M
Cash Flow from Investing Activities	--
Cash Flow from Financial Activities	$14.32M
Beginning Cash	$4.74M
End Cash	$13.60M
Increase/Decrease in Cash	$8.86M
Stock-Based Compensation	$0.77M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.66
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	0.71
Gross Margin	96.52%
Operating Margin	-50.77%
EBIT Margin	-50.77%
EBITDA Margin	-50.77%
Pre-Tax Profit Margin	-52.22%
Profit Margin	-52.22%
Free Cash Flow	$-5.46M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.58
Inventory Turnover	0.80
Receiveable Turnover	4.23
Days Sales in Receivables	86.19
Return on Equity	-76.05%
Return on Tangible Equity	-76.05%
Return on Assets	-30.55%
Return on Investments	-76.05%
Book Value Per Share	$4.74
Free Cash Flow per Share	$-2.87
Operating Cash Flow per Share	$-2.87

Data from Zacks Investment Research, Inc.